Business
Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date
RESEARCH TRIANGLE PARK, N.C., March 20, 2025--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it will report second quarter fiscal 2025 financial results after the market close on Thursday, April 3, 2025.
About this update from Simulations Plus, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/eb83160e004015266c16b2901e200362"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1DRrav.T5o67cKXtSTzoNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/eb83160e004015266c16b2901e200362","width":480,"height":480}},"lazy":false},{"type":"text","content":"Conference call to be on Thursday, April 3, 2025, at 5 p.m. ET","length":62,"tagName":"p","attribs":{}},{"type":"text","content":"RESEARCH TRIANGLE PARK, N.C., March 20, 2025--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it will report second quarter fiscal 2025 financial results after the market close on Thursday, April 3, 2025.","length":447,"tagName":"p"},{"type":"text","content":"Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 201-389-0879 (international) or by clicking on this Call me™ link to request a return call. The webcast can be accessed on the investor relations page of the Simulations Plus website at www.simulations-plus.com/investorscorporate-profile/corporate-profile/ where it will also be available for replay approximately one hour following the call.","length":654,"tagName":"p"},{"type":"text","content":"About Simulations Plus, Inc.","length":28,"tagName":"p"},{"type":"text","content":"With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based ph...